Strain Profile · NCBI Strain Taxon 880592
Save

Lacticaseibacillus rhamnosus R0011

◐ Food-origin
Sequenced
Public genome assembly available

Lacticaseibacillus rhamnosus R0011 is a well-studied probiotic strain with a research base spanning food technology, immunology, and gut health. In vitro studies have examined cytokine profiles in macrophage models in the context of immune regulation, and it has been investigated in combination with other lactobacilli in two randomized controlled trials — one in the context of adjunctive use in chronic rhinosinusitis and one in the context of antibiotic-associated diarrhea in healthy adults. Animal research has also explored interactions with gut microbiota composition. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 73 body-system-tagged papers that concern each system. Research coverage, not measured effect.

+3 more systems

Symptoms in the research

Share of this strain's 30 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

+7 more symptoms

Research

86 papers reference this strain in the probiotic database.

Match confidence
2025 ANIMAL
The Effect of Gut Microbiome Perturbation on the Bioavailability of Glycyrrhizic Acid in Rats
· Pharmaceutics
2025 OTHER
Metabolomic Signatures of Probiotic Secretomes Reveal Strain-Specific Biofunctional Potential: Insights from Lacticaseibacillus rhamnosus R0011 and Bifidobacterium longum R0175
· Borealis
2025 IN_VITRO
Probiotic secretomes and prebiotics modulate the adverse effects of polychlorinated biphenyls on in vitro intestinal outcomes
· Open MIND
2024 IN_VITRO
A Lacticaseibacillus rhamnosus secretome induces immunoregulatory transcriptional, functional and immunometabolic signatures in human THP-1 monocytes
· Scientific Reports
2023 RCT
Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study
· Frontiers in Gastroenterology
2022 ANIMAL
Maternal Administration Of Probiotic Lactobacilli Since Pre-Conception Programs Offspring Gut Microbiota Functions
· Current Developments in Nutrition
2022 IN_VITRO
Lacticaseibacillus rhamnosus R0011 secretome attenuates Salmonella enterica serovar Typhimurium secretome-induced intestinal epithelial cell monolayer damage and pro-inflammatory mediator production in intestinal epithelial cell and antigen-presenting cell co-cultures
· Frontiers in Microbiology
2022 ANIMAL
The Bioavailability of Glycyrrhizinic Acid Was Enhanced by Probiotic Lactobacillus rhamnosus R0011 Supplementation in Liver Fibrosis Rats
· Nutrients
2022 IN_VITRO
Strategies to improve the survival of probiotic Lacticaseibacillus rhamnosus R0011 during the production and storage of granola bars
· Canadian Journal of Microbiology
2022 IN_VITRO
Probiotics Exhibit Strain-Specific Protective Effects in T84 Cells Challenged With Clostridioides difficile-Infected Fecal Water
· Frontiers in Microbiology
2022 ANIMAL
The effects of antimicrobials and lipopolysaccharide on acute immune responsivity in pubertal male and female CD1 mice
· Comprehensive Psychoneuroendocrinology
2022 RCT
Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis
· Microorganisms
2021 RCT
Pathogen-Specific Effects of Probiotics in Children With Acute Gastroenteritis Seeking Emergency Care: A Randomized Trial
· Clinical Infectious Diseases
2021 ANIMAL
Lactobacillus rhamnosus R0011 Treatment Enhanced Efficacy of Capecitabine against Colon Cancer in Male Balb/c Mice
· Nutrition and Cancer
2021 IN_VITRO
Probiotic protection against dysregulated gut microbiota and intestinal cell functionality induced by «Clostridioides difficile»
·
2020 IN_VITRO
Temporal transcriptional, metabolic, and functional re-programming of THP-1 macrophages by the Lactobacillus rhamnosus R0011 secretome
· The Journal of Immunology
2020 IN_VITRO
Milk fermented with Lactobacillus rhamnosus R0011 induces a regulatory cytokine profile in LPS-challenged U937 and THP-1 macrophages
· Current Research in Food Science
2020 IN_VITRO
Characterization of casein-derived peptide bioactivity: Differential effects on angiotensin-converting enzyme inhibition and cytokine and nitric oxide production
· Journal of Dairy Science
2020 IN_VITRO
Fermentation of Wheat Bran and Whey Permeate by Mono-Cultures of Lacticaseibacillus rhamnosus Strains and Co-culture With Yeast Enhances Bioactive Properties
· Frontiers in Bioengineering and Biotechnology
2020 IN_VITRO
Secretome-Mediated Interactions with Intestinal Epithelial Cells: A Role for Secretome Components from Lactobacillus rhamnosus R0011 in the Attenuation of Salmonella enterica Serovar Typhimurium Secretome and TNF-α–Induced Proinflammatory Responses
· The Journal of Immunology
Browse all 86 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    Probiotic secretomes and prebiotics modulate the adverse effects of polychlorinated biphenyls on in vitro intestinal outcomes
    · Open MIND · 2025
    Source →
  2. [2]
    Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study
    · Frontiers in Gastroenterology · 2023
    PMID 41821821 →
  3. [3]
    Probiotics Exhibit Strain-Specific Protective Effects in T84 Cells Challenged With Clostridioides difficile-Infected Fecal Water
    · Frontiers in Microbiology · 2022
    PMID 35154018 →
  4. [4]
    Lacticaseibacillus rhamnosus R0011 secretome attenuates Salmonella enterica serovar Typhimurium secretome-induced intestinal epithelial cell monolayer damage and pro-inflammatory mediator production in intestinal epithelial cell and antigen-presenting cell co-cultures
    · Frontiers in Microbiology · 2022
    PMID 36246229 →
  5. [5]
    Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis
    · Microorganisms · 2022
    PMID 35889193 →
  6. [6]
    Secretome-Mediated Interactions with Intestinal Epithelial Cells: A Role for Secretome Components from Lactobacillus rhamnosus R0011 in the Attenuation of Salmonella enterica Serovar Typhimurium Secretome and TNF-α–Induced Proinflammatory Responses
    · The Journal of Immunology · 2020
    PMID 32238458 →
  7. [7]
    Suppression of Intestinal Epithelial Cell Chemokine Production by Lactobacillus rhamnosus R0011 and Lactobacillus helveticus R0389 Is Mediated by Secreted Bioactive Molecules
    · Frontiers in Immunology · 2018
    PMID 30524427 →
  8. [8]
    Probiotic Lacidofil® STRONG Mitigates the Antibiotic‐Induced Alteration of the Fecal microRNA Signature in Healthy Humans
    · The FASEB Journal · 2016
    Source →
  9. [9]
    Experience using probiotic strains Lactobacillus acidophilus R0052 and Lactobacillus rhamnosus R0011 in children with burn injuries
    Досвід використання пробіотичних штамів Lactobacillus acidophilus R0052 та Lactobacillus rhamnosus R0011 у дітей з опіковою травмою
    · GASTROENTEROLOGY · 2016
    Source →
  10. [10]
    Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) Reduce the Expression of Toll-Like Receptor 4 in Mice with Alcoholic Liver Disease
    · PLoS ONE · 2015
    PMID 25692549 →